NCT05672355View on ClinicalTrials.gov

A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia

PHASE2RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

January 12, 2026

Study Completion Date

January 12, 2026

Conditions
Chronic Lymphocytic LeukemiaCOVID-19 Infection
Interventions
PROCEDURE

Biospecimen Collection

Undergo blood sample collection

BIOLOGICAL

mRNA COVID-19 Vaccine

Given IM

BIOLOGICAL

Synthetic MVA-based SARS-CoV-2 Vaccine COH04S1

Given IM

Trial Locations (1)

91010

RECRUITING

City of Hope Medical Center, Duarte

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER